Serge Saxonov, Chief Executive Officer at 10x Genomics, Inc. (TXG), sold 25,000 shares at $78.23 ($2.0M) on 2026-09-22, disclosed to the SEC on 2026-09-24.
Scheduled sale ($2.0M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.23 | 1,000 | $78K | 3.9% |
| 2 | $79.62 | 2,000 | $159K | 7.8% |
| 3 | $80.90 | 9,300 | $752K | 37.1% |
| 4 | $81.83 | 9,900 | $810K | 39.9% |
| 5 | $82.36 | 2,800 | $231K | 11.4% |
| Total | $81.22 avg | 25,000 |
| $2.0M |
| 100% |
| Filing → |
| TXG | SELL | 2026-06-24 | $1.0M | — | Filing → |
| TXG | SELL | 2026-05-27 | $709K | — | Filing → |
| TXG | SELL | 2026-04-16 | $123K | — | Filing → |